Synapse - Solid Tumor Oncology Division

Results (146)

Efficacy and safety of telaglenastat plus cabozantinib vs placebo plus cabozantinib in patients with advanced renal cell carcinoma: The CANTATA randomized clinical trial

Journal Article

Tannir, N. M.; Agarwal, N.; Porta, C.; Lawrence, N. J.; Motzer, R.; McGregor, B.; Lee, R. J.; Jain, R. K.; Davis, N.; Appleman, L. J.; more...
JAMA Oncology (2022)

Fulltext@MSK | Save

Efficacy of preoperative mFOLFIRINOX vs mFOLFIRINOX plus hypofractionated radiotherapy for borderline resectable adenocarcinoma of the pancreas: The A021501 phase 2 randomized clinical trial

Journal Article

Katz, M. H. G.; Shi, Q.; Meyers, J.; Herman, J. M.; Chuong, M.; Wolpin, B. M.; Ahmad, S.; Marsh, R.; Schwartz, L.; Behr, S.; more...
JAMA Oncology (2022)

Fulltext@MSK | Save

Association between toxic effects and survival in patients with cancer and autoimmune disease treated with checkpoint inhibitor immunotherapy

Research Letter

Han, C. Y.; Fitzgerald, C.; Lee, M.; Valero, C.; Gönen, M.; Shoushtari, A.; Morris, L. G. T.
JAMA Oncology (2022)

Fulltext@MSK | Save

Association of low and intermediate combined positive scores with outcomes of treatment with pembrolizumab in patients with recurrent and metastatic head and neck squamous cell carcinoma: Secondary analysis of keynote 048

Research Letter

Yu, Y.; Zakeri, K.; Sherman, E. J.; Lee, N. Y.
JAMA Oncology (2022)

Fulltext@MSK | Save

Plant-based and ketogenic diets as diverging paths to address cancer: A review

Review

Shah, U. A.; Iyengar, N. M.
JAMA Oncology (2022)

Fulltext@MSK | Save

Association of high tumor mutation burden in non–small cell lung cancers with increased immune infiltration and improved clinical outcomes of PD-L1 blockade across PD-L1 expression levels

Journal Article

Ricciuti, B.; Wang, X.; Alessi, J. V.; Rizvi, H.; Mahadevan, N. R.; Li, Y. Y.; Polio, A.; Lindsay, J.; Umeton, R.; Sinha, R.; more...
JAMA Oncology (2022)

Fulltext@MSK | Save

Treatment with etirinotecan pegol for patients with metastatic breast cancer and brain metastases: Final results from the phase 3 ATTAIN randomized clinical trial

Journal Article

Tripathy, D.; Tolaney, S. M.; Seidman, A. D.; Anders, C. K.; Ibrahim, N.; Rugo, H. S.; Twelves, C.; Diéras, V.; Müller, V.; Du, Y.; more...
JAMA Oncology (2022)

Fulltext@MSK | Save

Breast cancer screening strategies for women with ATM, CHEK2, and PALB2 pathogenic variants: A comparative modeling analysis

Journal Article

Lowry, K. P.; Geuzinge, H. A.; Stout, N. K.; Alagoz, O.; Hampton, J.; Kerlikowske, K.; de Koning, H. J.; Miglioretti, D. L.; van Ravesteyn, N. T.; Schechter, C.; more...
JAMA Oncology (2022)

Fulltext@MSK | Save

Early readout on overall survival of patients with melanoma treated with immunotherapy using a novel imaging analysis

Journal Article

Dercle, L.; Zhao, B.; Gönen, M.; Moskowitz, C. S.; Firas, A.; Beylergil, V.; Connors, D. E.; Yang, H; Lu, L.; Fojo, T.; more...
JAMA Oncology (2022)

Fulltext@MSK | Save

Evaluation of substantial reduction in elective radiotherapy dose and field in patients with human papillomavirus–associated oropharyngeal carcinoma treated with definitive chemoradiotherapy

Journal Article

Tsai, C. J.; McBride, S. M.; Riaz, N.; Kang, J. J.; Spielsinger, D. J.; Waldenberg, T.; Gelblum, D.; Yu, Y.; Chen, L. C.; Zakeri, K.; more...
JAMA Oncology (2022)

Fulltext@MSK | Save